Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
Efavirenz and nevirapine are the most widely used agents for treatment of HIV in children. Sources of variability in their pharmacokinetics and its association with virological outcome and adverse events in African children are poorly characterised, thereby limiting treatment optimisation. To fill t...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Division of Clinical Pharmacology
2017
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Pharmacokinetics, pharmacogenetics and optimisation of treatment with non-nucleoside reverse transcriptase inhibitors in HIV-infected African children
- Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
- Lead optimisation of an indole based HIV-1 non-nucleoside reverse transcriptase inhibitor
- Indole- and diaryl ether-derived non-nucleoside reverse transcriptase inhibitors
- The rational design and synthesis of novel HIV non-nucleoside reverse transcriptase inhibitors
- The design and synthesis of novel HIV-1 non-nucleoside reverse transcriptase inhibitors
- Design and Synthesis of potent benzimidazolone HIV Non-nucleoside reverse transcriptase inhibitors